Leonard Sank, Director at ORAMED PHARMACEUTICALS INC. (ORMP), bought 54,517 shares at $3.58 ($196K) on 2019-07-17, disclosed to the SEC on 2019-07-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.47 | 20,000 | $69K | 35.4% |
| 2 | $3.58 | 20,000 | $72K | 36.6% |
| 3 | $3.74 | 10,020 | $37K | 19.1% |
| 4 | $3.86 | 4,497 | $17K | 8.9% |
| Total | $3.59 avg | 54,517 | $196K | 100% |
| Filing → |
| ORMP.OB | BUY | 2011-10-06 | $300K | — | Filing → |
| ORMP | BUY | 2008-01-17 | $5K | — | Filing → |
| ORMP | BUY | 2008-01-09 | $7K | — | Filing → |